Literature DB >> 7613960

Mediastinal lymph node dissection for lung cancer. The Memorial experience.

N Martini1.   

Abstract

A mediastinal lymph node dissection as opposed to lymph node sampling should be an integral part of the operation in all patients with resectable lung cancers. A systematic mediastinal node dissection affords the most accurate staging and a long-term survival in some patients when the positive regional nodes are also removed. It is safe and easy to do, adds only 20 to 30 minutes to the surgical procedure, and morbidity is minimal. Our reported survival data have been based on the routine use of mediastinal lymph node dissection in conjunction with pulmonary resection. Techniques of lymph node dissection for both right- and left-sided tumors are described along with a historical background of their evolution.

Entities:  

Mesh:

Year:  1995        PMID: 7613960

Source DB:  PubMed          Journal:  Chest Surg Clin N Am        ISSN: 1052-3359


  13 in total

1.  Thoracoscopic lobectomy is a safe and versatile procedure: experience with 500 consecutive patients.

Authors:  Mark W Onaitis; Rebecca P Petersen; Stafford S Balderson; Eric Toloza; William R Burfeind; David H Harpole; Thomas A D'Amico
Journal:  Ann Surg       Date:  2006-09       Impact factor: 12.969

2.  Video-assisted thoracoscopic lobectomy reduces cytokine production more than conventional open lobectomy.

Authors:  K Sugi; Y Kaneda; K Esato
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2000-03

Review 3.  Mediastinal lymph nodes: ignore? sample? dissect? The role of mediastinal node dissection in the surgical management of primary lung cancer.

Authors:  Jean Deslauriers
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-08-09

4.  Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: results of the American College of Surgery Oncology Group Z0030 Trial.

Authors:  Gail E Darling; Mark S Allen; Paul A Decker; Karla Ballman; Richard A Malthaner; Richard I Inculet; David R Jones; Robert J McKenna; Rodney J Landreneau; Valerie W Rusch; Joe B Putnam
Journal:  J Thorac Cardiovasc Surg       Date:  2011-03       Impact factor: 5.209

5.  Intraoperative frozen sections of the regional lymph nodes contribute to surgical decision-making in non-small cell lung cancer patients.

Authors:  Wei Li; Xue-Ning Yang; Ri-Qiang Liao; Qiang Nie; Song Dong; Hao-Ran Zhai; Yi-Long Wu; Wen-Zhao Zhong
Journal:  J Thorac Dis       Date:  2016-08       Impact factor: 2.895

6.  The clinical value of a new method of functional lymph node dissection in video-assisted thoracic surgery right non-small cell lung cancer radical resection.

Authors:  Sui Chen; Shijie Huang; Shaobin Yu; Ziyang Han; Lei Gao; Zhimin Shen; Mingqiang Kang
Journal:  J Thorac Dis       Date:  2019-02       Impact factor: 2.895

7.  A prediction model for lymph node metastases using pathologic features in patients intraoperatively diagnosed as stage I non-small cell lung cancer.

Authors:  Fei Zhao; Yue Zhou; Peng-Fei Ge; Chen-Jun Huang; Yue Yu; Jun Li; Yun-Gang Sun; Yang-Chun Meng; Jian-Xia Xu; Ting Jiang; Zhi-Xuan Zhang; Jin-Peng Sun; Wei Wang
Journal:  BMC Cancer       Date:  2017-04-13       Impact factor: 4.430

8.  Preoperative chemotherapy and radiotherapy concomitant to cetuximab in resectable stage IIIB NSCLC: a multicentre phase 2 trial (SAKK 16/08).

Authors:  Alessandra Curioni-Fontecedro; Jean Yannis Perentes; Hans Gelpke; Alexandros Xyrafas; Hasna Bouchaab; Nicolas Mach; Oscar Matzinger; Nina Stojcheva; Martin Frueh; Walter Weder; Richard Cathomas; Piera Gargiulo; Lukas Bubendorf; Miklos Pless; Daniel Betticher; Solange Peters
Journal:  Br J Cancer       Date:  2019-04-16       Impact factor: 7.640

Review 9.  Non-small cell lung cancer staging: proposed revisions to the TNM system.

Authors:  Bryan J Schneider
Journal:  Cancer Imaging       Date:  2008-09-30       Impact factor: 3.909

10.  Prognostic significance of centrosomal protein 55 in stage I pulmonary adenocarcinoma after radical resection.

Authors:  Wenpeng Jiang; Zhou Wang; Gang Chen; Yang Jia
Journal:  Thorac Cancer       Date:  2016-01-04       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.